We would like to introduce a project aimed at the integration of imaging diagnosis and treatment using radiopharmaceuticals!
Theranostics, which closely links treatment and diagnosis, is expected to contribute to personalized medicine and the effective use of healthcare costs. By developing therapeutic agents using radioisotopes (RI: radioactive isotopes) that emit alpha particles, a type of radiation, along with companion diagnostic agents, we aim to realize theranostics. We have completed the CRADLE building and established the "Theranostics Production Technology Center." By placing a dedicated department, we will achieve the early supply of alpha-emitting radionuclides from the CRADLE building, while further strengthening collaboration between the drug discovery laboratory located within the same facility and the Chiba factory, thereby accelerating the development of theranostics drug discovery. 【Functions of the facility】 ■ Production of 225Ac and PET radionuclides ■ Handling of 177Lu and 211At, among others ■ Production of investigational drugs ■ Production of research-use RIs *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company will contribute to people's healthy lives through the exploration of biological functions, based on the technical expertise and trust cultivated in the field of nuclear medicine imaging diagnosis. As a leading company in radiopharmaceuticals, we will contribute to overcoming medical challenges in the field of "molecular imaging." Please feel free to contact us if you have any inquiries.